Riskpilot← Back to searchSign inGet full accessTeramed A/S
A/SActiveCVR 40450572Tjørnevej 7Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20195 employees
Revenue 2025
DKK 2,2M
+19% vs 2024
EBITDA margin
15.9%
+22% vs 2024
Equity ratio
30.5%
Financial strength
Net profit 2025
DKK 330K
+1753% vs 2024
| Revenue | DKK 2,2M | +19% |
| EBITDA | DKK 353K | +22% |
| Net profit | DKK 330K | +1753% |
| Total assets | DKK 3M | +31% |
| Equity | DKK 920K | +56% |
| Employees | 5 | — |
Legal name
Teramed A/S
CVR number
40450572
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. april 2019
Share capital
DKK 510.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-07-31
Financial year
January – December
Signatory rights
Selskabet tegnes af Erik Viggo From og Dorte Munch Ekstrand i forening.
Company purpose
Selskabets formål er handel med udstyr til fysioterapi samt efter bestyrelsens skøn dermed beslægtet virksomhed.
Address
Tjørnevej 7
Phone
+4531187983
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 606 | 2.178 | 1.959 | 2.142 | 1.867 | 2.218 |
| Staff expenses | -2.576 | -2.414 | -2.275 | -1.710 | -1.543 | -1.864 |
| EBITDA | -1.970 | -236 | -316 | 432 | 291 | 353 |
| Depreciation & amort. | -150 | -150 | -150 | 150 | 150 | -0 |
| EBIT | -2.120 | -386 | -466 | 282 | 141 | 353 |
| Net financials | -73 | -81 | -66 | -65 | -123 | -24 |
| Profit before tax | -2.193 | -467 | -531 | 217 | 18 | 330 |
| Tax | -482 | 337 | -0 | 145 | -0 | -0 |
| Net profit | -1.711 | -805 | -531 | 72 | 18 | 330 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 3.415 | 4.169 | 2.959 | 3.018 | 2.295 | 3.010 |
| Equity | 289 | -516 | -1.047 | 572 | 590 | 920 |
| Long-term debt | 0 | 2.097 | 2.123 | 932 | 967 | 1.005 |
| Short-term debt | 3.127 | 2.588 | 1.882 | 1.513 | 738 | 1.086 |
| Total debt | 3.127 | 4.685 | 4.006 | 2.445 | 1.705 | 2.091 |
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
20202025
Equity ratio
30.5%
This company
38.2%
Market median
+20% vs market
20202025
Return on equity
35.8%
This company
18.4%
Market median
+95% vs market
20202025
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
20202025
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
20202025
Debt / equity
2.27×
This company
0.62×
Market median
-266% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via CVR / Virk · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via CVR / Virk · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via CVR / Virk · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via CVR / Virk · Period 2020-08-01 – 2021-07-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-14 – 2020-07-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EV Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JERSIE HOLDING ApS | Company | 50.0% | 50.0% | 2019 |
EKSTRAND HOLDING ApS | Company | 50.0% | 50.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JERSIE HOLDING ApS
Teramed A/S Board members of Teramed A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Viggo From | Management | 0 companies |
| Kenneth Myrthue Sørensen | Chairman | 0 companies |
| Dorte Munch Ekstrand | Board of Directors | 0 companies |
| Kurt Christensen | Chairman | 0 companies |